Pneumococcal empyema: Impact of immunization [1]

Pediatric Infectious Disease Journal

Volumn 25, Issue 9, 2006, Pages 854-

  Jhaveri, Ravi ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE; SIALIDASE;

DISEASE PREDISPOSITION; DRUG MECHANISM; EMPYEMA; HUMAN; IN VITRO STUDY; INFLUENZA; LETTER; PATHOGENESIS; PEDIATRICS; PRIORITY JOURNAL; PUBLIC HEALTH; RESPIRATORY EPITHELIUM; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

EMPYEMA, PLEURAL; HUMANS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; UTAH;

EID: 33748298939     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000234060.06508.c2     Document Type: Letter

References (4)

1. Byington CL, Korgenski K, Daly J, Ampofo K, Pavia A, Mason EO. Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Pediatr Infect Dis J. 2006;25:250-254.
2. Utah Department of Health, Office of Epidemiology, Influenza Home. Salt Lake City, UT: Utah Department of Health, 2006.
3. McCullers JA, Bartmess KC. Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae. J Infect Dis. 2003;187:1000-1009.
4. Peltola VT, McCullers JA. Respiratory viruses predisposing to bacterial infections: role of neuraminidase. Pediatr Infect Dis J. 2004;23(suppl):S87-S97.